We are pleased to share that the International Journal of Neonatal Screening (IJNS) was awarded an increased Impact Factor of 4.0 in the 2023 Journal Citation Reports™ released by Clarivate in June 2024. IJNS ranks in Q1 (12 among 186 titles) in “PEDIATRICS” and Q1 (40 among 191 titles) in “GENETICS & HEREDITY”. Additionally, according to data released by Scopus (Elsevier), IJNS received an updated CiteScore™ of 6.7, an increase of 34% compared with the 2021 metric. IJNS’s CiteScore ranks as follows: Q1 (32 out of 330 journals) in "Pediatrics, Perinatology and Child Health" Q1 (25 out of 209 journals) in "Obstetrics and Gynecology" Q1 (4 out of 29 journals) in "Immunology and Microbiology (miscellaneous)" For further statistics, please visit https://lnkd.in/dumwUUrq.
International Journal of Neonatal Screening
Book and Periodical Publishing
An international peer-reviewed open access journal on neonatal screening and neonatal medicine published by MDPI. #ISNS
About us
International Journal of Neonatal Screening (ISSN 2409-515X) is an international peer-reviewed open access journal on neonatal screening and neonatal medicine. It is the official journal of the International Society for Neonatal Screening (ISNS) published quarterly online by MDPI. IJNS is also the official journal of the German Society for Neonatal Screening (DGNS), the Japanese Society for Neonatal Screening (JSNS) and the Association of Public Health Laboratories (APHL)–Newborn Screening & Genetics Program which are affiliated societies and program to the journal.
- Website
-
https://www.mdpi.com/journal/IJNS
External link for International Journal of Neonatal Screening
- Industry
- Book and Periodical Publishing
- Company size
- 2-10 employees
- Headquarters
- Basel
- Type
- Privately Held
- Founded
- 2015
Locations
-
Primary
Basel, CH
Employees at International Journal of Neonatal Screening
Updates
-
Some preterm and sick #neonates have altered biochemical profiles and follow-up #newbornscreening (#NBS) collections are recommended. The Victorian NBS program historically recommended repeat collections for babies with birth weight < 1500 g (managed by the maternity service provider) and 3 weeks post-transfusion (managed by the laboratory). Greaves & colleagues aimed to determine adherence to current guidelines and review the guidelines to improve NBS performance: Managing Newborn Screening Repeat Collections for Sick and Preterm Neonates https://lnkd.in/dmNhpUDJ
-
International Journal of Neonatal Screening reposted this
Happy Newborn Screening Awareness Month! Did you know that the 2024 APHL Newborn Screening Symposium will be held in Omaha, Nebraska on October 20-24? Register today and learn about current and emerging topics in newborn screening and genetics. Connect with industry partners, colleagues and friends and renew your passion for newborn screening! Early Bird registration ends September 19th. buff.ly/2TQP2jk #APHLNBS #2024NBS
-
Driven by technological innovations, #newbornscreening (#NBS) panels have been expanded and the development of genomic NBS pilot programs is rapidly progressing. Decisions on disease selection for NBS are still based on the Wilson and Jungner criteria published in 1968. Despite this uniform reference, interpretation of the WJ criteria and actual disease selection for NBS programs are highly variable. Schnabel-Besson & colleagues performed a systematic literature search to evaluate the applicability of the WJ criteria for current and future NBS programs and the need for adaptation: Wilson and Jungner Revisited: Are Screening Criteria Fit for the 21st Century? https://lnkd.in/dFrFTVzk
-
Understanding whether the long-term follow-up system is working for families is critical to measuring the success of #newbornscreening (#NBS) and understanding why some families are lost to follow-up. Quesada & colleagues recruited caregivers were from six pediatric specialty care clinics. Data were gathered from caregivers via five focus groups and one individual interview: A Qualitative Study on Engaged Families’ Experiences with Long-Term Follow-Up Care in the Colorado/Wyoming Newborn Screening System https://lnkd.in/dJxvyRj3
-
In 2015, #UK #newbornscreening (#NBS) laboratory guidelines were introduced to standardize dried blood spot specimen quality acceptance and specify a minimum acceptable DBS diameter of ≥7 mm. To assess inter-laboratory variability in specimen acceptance/rejection, two sets of colored scanned images of both good and poor-quality DBS specimens were distributed to all 16 U.K. NBS laboratories for evaluation as part of an external quality assurance assessment: Consistency in the Assessment of Dried Blood Spot Specimen Size and Quality in U.K. Newborn Screening Laboratories by Moat & colleagues https://lnkd.in/dQAv6hPk
-
Hereditary tyrosinemia type I (HT1), or hepatorenal #tyrosinemia, is an amino acid disorder which may cause hepatic failure as well as renal and neurologic comorbidities. Early detection of this disorder is possible with #newbornscreening. The objective of the study by Cavan et al. is to describe the clinical, biochemical, and molecular characteristics of Filipino patients diagnosed with HT1 through the expansion of the Philippine NBS program in 2014: Clinical, Biochemical, and Molecular Characteristics of Filipino Patients with Tyrosinemia Type 1 https://lnkd.in/ddiRbM77
-
Call for papers: This Special Issue of the International Journal of Neonatal Screening on #Psychosocial Burden of Positive #NewbornScreening will focus on the potential impact of positive #NBS on the #child and their #family, particularly when the outcome leads to a degree of uncertainty, and how this can potentially be managed to reduce associated negative psychosocial outcomes. Learn more details here: https://lnkd.in/dRXNiMDs Guest Editors: Dr. Jane Chudleigh and Leah Hecht Submission deadline: 31 October 2024
-
Call for papers: This Special Issue will focus on key contemporary issues surrounding #newbornscreening for #CongenitalHypothyroidism (CH). These key issues include improving and evaluating testing algorithms (e.g., CLIR), establishing CH screening in low- and middle-income countries, and evaluating #costeffectiveness and long-term outcomes. Additional considerations include screening in special populations, e.g., preterm infants, and screening for central hypothyroidism, monogenic CH, and MCT-8. Learn more details here: https://lnkd.in/dNMSpnwn Guest Editors: Dr. Ernest M. Post, Dr. Natasha Heather and Dr. Ralph Fingerhut Submission deadline: 31 December 2024
-
International Journal of Neonatal Screening reposted this
An important paper on the Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023) by Bradford L. Therrell, et al. Int. J. Neonatal Screen. 2024, 10(2), 38; https://lnkd.in/dRUWdNW6 - An excellent state of the art to plan future action plans.